Header Logo

Connection

Mary Fidler to Patient Reported Outcome Measures

Back to Details
This is a "connection" page, showing publications Mary Fidler has written about Patient Reported Outcome Measures.
Mary Fidler
Connection Strength
0.114
Patient Reported Outcome Measures
  1. Health-Related Quality of Life in KEYNOTE-010: a Phase II/III Study of Pembrolizumab Versus Docetaxel in Patients With Previously Treated Advanced, Programmed Death Ligand 1-Expressing NSCLC. J Thorac Oncol. 2019 05; 14(5):793-801.
    View in: PubMed
    Score: 0.114
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.